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Abstract Myomectomy remains the surgical option of
choice for women with symptomatic leiomyomata who
desire uterine conservation or in particular future fertil-
ity. The ability to enucleate leiomyomata and repair the
uterus with a multilayer-sutured closure is both crucial
and technically challenging. Advanced gynecologic
pathology and the surgical limitations of conventional
laparoscopy have often been cited as impediments to not
only these critical steps but also to converting a myomec-
tomy from a procedure predominantly performed by lap-
arotomy to one accomplished by laparoscopy. Recently,
the use of robotic technology as a means to facilitate the
laparoscopic completion of a myomectomy was intro-
duced. Advantages to this approach have been the
improved dexterity and precision of the instruments cou-
pled with three-dimensional imaging. Published prelimi-
nary data have shown the feasibility and safety to this
approach. This paper will outline a safe and eYcient sur-
gical technique for completing a robot-assisted laparo-
scopic myomectomy with the da Vinci® surgical system.
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Introduction
Leiomyomata are the most common pelvic tumor in
women. These benign tumors of Wbrous tissue and
smooth muscle are often implicated in excessive bleed-
ing, pain, pressure, and/or infertility. Although newer
modalities such as uterine artery embolization exist,
myomectomy remains the surgical option of choice for
women desiring uterine conservation or in particular
future fertility [1, 2]. As a result of the advent of mod-
ern-day minimally invasive surgery techniques, many
cases of intramural and subserous leiomyomata are
managed by laparoscopy today. Despite the increasing
acceptance of laparoscopy, laparotomy still remains
the primary route of conservative surgical management
for symptomatic leiomyomata, not approachable by
hysteroscopy.
There is no doubt that the management of leiomyo-
mata endoscopically is one of the more challenging
procedures in minimally invasive surgery and requires
a skilled surgeon. The ability to enucleate leiomyomata
and repair the uterus with a multilayer-sutured closure
is both crucial and technically challenging. These issues
are thought to aVect conversion rates to laparotomy
and may play a role in cases of uterine rupture. Much
of the steadfast adherence to the open approach has
been due to the diYculties encountered with conven-
tional laparoscopy and its associated learning curves
[3, 4].
The use of robot-assisted technology may provide a
means to overcome the challenges encountered with
hysterotomy, enucleation, repair, and extraction that
are seen with conventional laparoscopic management
of leiomyomata. In other words, the use of computer-
assisted surgery may provide surgeons with improved
dexterity and precision coupled with advanced imaging
and allow the endoscopic approach to be more accu-
rately modeled after open surgical techniques. The fol-
lowing paper will describe the use of the da Vinci®
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Food and Drug Administration (FDA)-approved
robotic device for use in gynecologic surgery as of
April 2005. The focus will be on both surgical tech-
nique and instrumentation.
The da Vinci® surgical system
The da Vinci® surgical system is a laparoscopic assist
device that is comprised of three components that
exists as core technology within two platforms, the
Standard and S™ systems. The Wrst component is the
surgeon console, which is located remotely, several feet
from the patient bedside. In theory, this can also be
located in an adjoining room. The surgeon seated at
this console is able to control robot-assisted instru-
ments, a camera, and an energy source within the
patient with the aide of a stereoscopic viewer, hand
manipulators and foot pedals.
The second component of the da Vinci® surgical sys-
tem is the InSite® Vision System, which provides three-
dimensional imaging through a 12 mm endoscope. A
5 mm endoscope is also available; however, this only
provides two-dimensional imaging therefore these
authors typically incorporate a 12 mm endoscope.
The third component of the da Vinci® surgical sys-
tem is the patient-side cart with robotic arms and
EndoWrist® instruments. Currently the system is avail-
able with either three or four robotic arms. One of the
arms holds the endoscope while the other two to three
arms hold the various EndoWrist® instruments, which
come in either 8 or 5 mm sizes.
The EndoWrist® instruments are unique in that they
lack haptic or tactile feedback for the surgeon operat-
ing them at the console. They do however possess a
wrist-like mechanism that allows seven degrees of
movement, thereby replicating the full range of motion
of the surgeon’s hand. This in turn eliminates the ful-
crum eVect seen with conventional laparoscopy. A
series of EndoWrist® instruments, such as needle driv-
ers, scissors, and graspers can be interchanged on
either of the lateral robotic arms.
Set-up
Patient positioning is analogous to conventional lapa-
roscopy. All patients are placed in low dorsal lithotomy
position with arms padded and tucked at their sides
after general endotracheal anesthesia is administered.
Anti-skid measures should be incorporated at this time
with either the proper use of shoulder braces or a foam
egg-crate mattress directly behind the patient’s upper
back in order to avoid patient slippage during the use
of Trendelenburg.
An examination under anesthesia is performed prior
to the patient being prepped and draped in order to
plan trocar placement. The bladder is drained with a
Foley catheter and the stomach is evacuated with an
orogastric tube. Pre-operatively, patients should have
undergone a mechanical bowel prep in order to ade-
quately decompress the distal colon and rectosigmoid
for improved visualization of the pelvis as well as mini-
mize any risk of injury. Based on surgeon preference, a
variety of uterine manipulators can then be placed in
order to facilitate the robot-assisted myomectomy.
These authors utilize a ZUMI® uterine manipulator
(Cooper Surgical®, Trumbull, CT, USA) (Fig. 1).
Pneumoperitoneum is obtained with a Veress nee-
dle technique followed by placement of either four or
Wve trocars, depending on whether or not the patient-
side cart has three or four robotic arms. These authors
utilize a three-armed patient-side cart with the acces-
sory port placed on the patient’s right side (Fig. 2). A
12 mm port is placed either at or above the umbilicus
depending on the size of the uterus. This port accom-
modates the endoscope which provides the three-
dimensional imaging. As a general rule, at least a
hands-breadth distance or approximately 8–10 cm
between the endoscope and top of an elevated uterus
or leiomyoma during manipulation is necessary in
order to allow for an adequate working distance
between the endoscope and the uterine fundus. This is
a critical concept during myomectomy because the
enucleation process will result in the leiomyoma tele-
scoping out toward the endoscope. This loss of optical
working distance must be compensated for at the
beginning of the case or else instrument maneuverabil-
ity will be compromised. Two 8 mm ports that mount
Fig. 1 ZUMI® uterine manipulator (Cooper Surgical®) 123
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are placed in the left and right lower quadrants, respec-
tively. For larger uteri or leiomyomata, these ports are
moved more cephalad. A fourth trocar serves as an
accessory port and can be placed between the camera
port and either the left or right lower quadrant ports.
This is typically a 12–15 mm port in order to facilitate
introduction of suture as well as instruments used for
retraction, suction/irrigation, and specimen removal
via a tissue morcellator. An alternative placement for
this large accessory port is in either the left or right
lower quadrant. The respective 8 mm robotic trocar
can then be telescoped through the accessory port
without loss of pneumoperitoneum. A smaller trocar
can then be used in the traditional accessory port
location.
Once all desired ports are in place, the patient is
placed in steep Trendelenburg. The patient-side cart
with robotic arms is brought between the patient’s legs
and docked. This means that each port is attached to
the assigned robotic arm with the exception of the
accessory port. The bedside surgeon is responsible for
EndoWrist® instrument exchanges and management of
any accessory port activity such as providing suction/
irrigation. At this point, the anesthesiologist must be
notiWed that the operating room table cannot be
moved unless the patient side-cart is undocked.
EndoWrist® instrumentation
A variety of EndoWrist® instruments are available for
use during a myomectomy. Although traditional surgi-
cal instrumentation such as DeBakey forceps and
curved scissors are available on this platform, newer
multifunctional EndoWrist® instruments such as the
bipolar PK™ dissecting forceps, hot shears (monopolar
curved shears), tenaculum and mega needle driver
allow for safe and eYcient completion of a myomec-
tomy with minimal instrument exchanges (Fig. 3).
Advantages of newer energy sources such as the bipo-
lar PK™ dissecting forceps are its ability to facilitate
the enucleation process while providing active feed-
back control over the power output being applied. The
use of this particular instrument does require integra-
tion with a Gyrus ACMI generator that incorporates
PlasmaKinetic (PK) vapor pulse coagulation (VPC).
This results in improved hemostasis with minimal
thermal spread, tissue sticking, and heating of the
instrument.
Robot-assisted laparoscopic myomectomy technique
An approach that is modeled after open surgical tech-
nique is critical to the success of a robot-assisted lapa-
roscopic approach to myomectomy. Determining the
size and location of leiomyomata pre-operatively is
also important. The authors recommend that all
patients undergo appropriate radiologic imaging prior
to myomectomy. Although ultrasound is diagnostic in
the majority of cases, it has been the bias of the authors
to utilize magnetic resonance imaging (MRI) in all
patients prior to surgery in order to assess the size,
number, and location of leiomyomata as well as rule
out adenomyosis. This information also allows for a
strategic uterine incision or hysterotomy to be per-
formed.
Intra-operatively after the location of the leiomy-
oma to be removed is assessed, a dilute concentration
of vasopressin is injected into the myometrium sur-
rounding the myoma, as an adjunct for hemostasis
(Fig. 4). This is facilitated by a 7 in. 22 gauge spinal
Fig. 2 Port placement (three-armed patient-side cart). The cam-
era port (A) is 12 mm either in the umbilicus or above depending
on size of the uterus. The lateral ports (B) are 8 mm da Vinci®
ports in the lower quadrants of the abdomen. A 10–12 mm assist
port is placed between the camera port and the right lower quad-
rant port123
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wall. The use of vasopressin, pneumoperitoneum, and
the judicious use of electrosurgery all contribute to
hemostasis and adequate visualization during the pro-
cedure.
Each case is begun with bipolar PK™ dissecting for-
ceps or a non-energized Cadiere forceps® on the left
arm and hot shears or a permanent cautery hook (both
monopolar devices) on the right arm. This designation
can be varied based on surgeon preference. It is impor-
tant to note that the monopolar current provided to the
hot shears is in coagulation mode therefore the power
settings on the radio-frequency generator are typically
kept to a minimum of 35 in order to avoid the risks of
excessive energy delivery. Factory default settings on
the Gyrus ACMI generator are used for the PK™ dis-
secting forceps.
Once adequate blanching of the myometrium sur-
rounding the leiomyoma is noted, a hysterotomy is
made with a monopolar device (Fig. 5). Although this
incision is typically done horizontally in a conventional
laparoscopic case in order to facilitate suturing, with
the robot-assist device, the hysterotomy can be made
in a longitudinal axis (as would otherwise be done in an
open myomectomy) as the surgeon is less limited in
terms of manual dexterity for the suturing process.
Once the leiomyoma capsule is identiWed and the
appropriate plane is found, the tumor is enucleated uti-
lizing a monopolar device on one arm and a grasping
instrument on the other. Additional traction/counter-
traction on the leiomyoma can be provided by the bed-
side assistant with a conventional laparoscopic tenacu-
lum or corkscrew. If a fourth arm is present, then an
EndoWrist® tenaculum can be utilized (Fig. 6). Careful
attention to hemostasis should be paid throughout this
portion of the procedure, particularly as the base of the
leiomyoma is encountered. Excessive traction can pre-
maturely avulse the tumor and result in bleeding. The
hysterotomy incision can be enlarged as needed in
order to facilitate the enucleation process.
After removal of the leiomyoma is complete, it is
placed in the posterior cul-de-sac for retrieval at the
end of the case. Larger specimens can be placed in one
of the paracolic gutters. Typically the EndoWrist®
instruments are exchanged for both a large needle
driver on the left arm and a mega needle driver on the
Fig. 3 Endowrist® instruments
Fig. 4 A dilute concentration of vasopressin is injected into the
myometrium surrounding the myoma, as an adjunct for hemostasis123
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grip, minimizes needle movement during passage
through the thick myometrium and facilitates closure
of the defect. The deep layers of the myomectomy inci-
sion are then repaired in a multilayer fashion. Either
interrupted sutures of 0-Vicryl™ on CT-2 needles cut to
six inches or running sutures of 0-Vicryl™ on CT-2 nee-
dles cut to 11 inches can be used. Suture passage and
exchange are managed through the accessory port by
the bedside assistant. The increased articulation and
dexterity of the EndoWrist® instruments facilitates
intracorporeal suturing and closure of the uterine
defect regardless of incision orientation. Once the deep
layers of the myometrium are reapproximated, the
uterine serosa is closed with a running baseball stitch
that utilizes 3-0-Vicryl™ on an SH needle (Fig. 7).
At this point, there are several noteworthy points. If
multiple leiomyomas are to be removed, it is the pref-
erence of the authors to repair each uterine defect after
enucleation of a leiomyoma before moving on to
another tumor in order to take advantage of the eVects
of the vasopressin at that site. Maximizing the number
of leiomyomas extracted through a given hysterotomy
is advisable and decreases the number of uterine inci-
sions. Finally, whether single or multiple, specimens
are retrieved at the end of the case, again, in order to
take advantage of the eVects of the vasopressin and
minimize blood loss from an unrepaired uterine inci-
sion. Careful attention should be paid to keeping an
accurate count of the number of leiomyoma enucleated
and if need be they should be tagged with long suture
in order to avoid loss within the abdominal cavity. This
is recommended for smaller specimens.
Prior to extraction of leiomyomata from the abdo-
men, the robot-assist device is undocked. Specimen
retrieval is accomplished with the use of a serrated–
edge tissue morcellator (WISAP®) that is placed
through the accessory port (Fig. 8). Next, all operative
sites are irrigated and a low insuZation pressure check
is performed to ensure hemostasis. Once hemostasis is
conWrmed, an adhesion barrier is placed over all uter-
ine incisions [5, 6]. The authors typically employ a
slurry of Wnely chopped SepraWlm® (Genzyme®) in
35 cc of normal saline. This is introduced through one
of the trocars via a red rubber catheter and 60 ml cath-
eter tip syringe (Fig. 9). All instruments are then
removed from the patient’s abdomen and pneumoperi-
toneum released. Port sites are closed accordingly.
Conclusion
Based on the described surgical technique, a myomec-
tomy that adheres to open surgical principles can be
Fig. 5 Hysterotomy with an Endowrist® permanent cautery hook
Fig. 6 Endowrist® tenaculum providing counter-traction and
facilitating enucleation of the leiomyoma
Fig. 7 Closure of the uterine serosa is accomplished with a run-
ning baseball stitch 3-0-vicryl suture on an SH needle is utilized123
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device such as the da Vinci® surgical system. This
approach to robot-assisted laparoscopic myomectomy
has been used successfully by the authors for the past
Wve years [7]. Critical to the success of this technique
has been a thorough understanding of all facets of
robotic instrumentation including its limitations.
Although an absence of haptic or tactile feedback may
be viewed as a limitation during a robot-assisted lapa-
roscopic myomectomy, the authors Wnd that both the
improved visualization and instrument dexterity in this
approach overcome any diYculties that may be
encountered with the dissection. This is by no means
the only way to perform a robot-assisted laparoscopic
myomectomy but represents a safe and eYcient way of
approaching a common gynecologic problem.
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